OCHSNER COMMUNITY CLINICAL ONCOLOGY PROGRAM

OCHSNER 社区临床肿瘤学计划

基本信息

批准号：
3557688
负责人：
CARL G KARDINAL
金额：
$ 29.64万
依托单位：
OCHSNER CLINIC FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
1983
资助国家：
美国
起止时间：
1983-09-01 至 1995-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/3557688
关键词：
cancer information system cancer registry /resource cancer rehabilitation /care clinical trials community health services cooperative study health care referral /consultation human subject human therapy evaluation medical outreach /case finding neoplasm /cancer education neoplasm /cancer therapy patient /disease registry pediatric neoplasm /cancer pharmacy administration primary care physician

项目摘要

The Ochsner CCOP, an enthusiastic, multicomponent clinical research unit, was originally funded during CCOP I, and competitively renewed during CCOP II. The Ochsner CCOP has integrated the resources of a major medical center, the Ochsner Medical Institutions, with community-based oncologists in the true spirit of the CCOP RFA. Participation of Ochsner CCOP investigators into all aspects of research base activities has resulted in a modest but significant CCOP bibliography of ten publication which are included in LIterature Cited. During CCOP I, the Ochsner CCOP worked vigorously to develop an effective network in southern Louisiana and southern Mississippi for participation in cancer treatment protocols. During CCOP II, the Ochsner CCOP further enlarged its network to include the New Orleans Children's Hospital which has expanded the scope from an adult only CCOP to one with an active pediatric component. Also during CCOP II, there was a commitment to the development of the basic mechanisms for cancer control research. This was accomplished by the recruitment of a Cancer Control Coordinator, and the involvement of non-oncology physicians into cancer control trials. The Ochsner CCOP has evolved into the largest cancer clinical trials program in the state of Louisiana, and a major clinical trials force in the state of Mississippi. The goals of the Ochsner CCOP for the new grant period are four-fold: 1. To increase our already high accrual to cancer treatment protocols. This will be accomplished through the now increased oncology staff at three components: Ochsner Clinic of New Orleans, Ochsner Clinic of Baton Rouge, and Biloxi, Mississippi, and through the addition of a new component, the Methodist Cancer Center of East New Orleans. 2. To further expand our cancer control efforts with emphasis on increased participation of our Mississippi components. 3. To enhance minority participation in CCOP activities by the inclusion of a new CCOP components, Methodist Cancer Center of East New Orleans. The patient mix at the methodist Cancer Center is greater than 50% minority group patients. 4. To consolidate the CCOP research efforts by emphasizing participation in three major research bases. The primary research base is NCCTG, which includes non-conflicting ECOG protocols. The other major research bases are NSABP and POG. The Ochsner CCOP will also be affiliated with M.D. Anderson primarily for cancer control, but selected non-conflicting cancer treatment protocols will be utilized. The Ochsner CCOP has a proven track record as an efficient, disciplined team and plans to continue to contribute significantly to the NCI's clinical research efforts. The Ochsner CCOP will continue to emphasize quality, quantity (high accrual) and economy (low cost per case accrued).

Ochsner CCOP 是一个热情的、多元化的临床研究单位，最初在 CCOP I 期间获得资助，并在 CCOP 期间竞争性更新二. Ochsner CCOP 整合了各大医疗机构的资源中心，Ochsner 医疗机构，以及社区肿瘤学家本着 CCOP RFA 的真正精神。 Ochsner CCOP 的参与调查人员对研究基地活动的各个方面进行了调查，结果一个适度但重要的 CCOP 参考书目，包含十种出版物，它们是包含在引用的文献中。在 CCOP I 期间，Ochsner CCOP 积极致力于制定有效的路易斯安那州南部和密西西比州南部的网络参与癌症治疗方案。在 CCOP II 期间，Ochsner CCOP 进一步扩大其网络，将新奥尔良儿童医院纳入其中已将范围从仅限成人的 CCOP 扩大到具有活跃活动的 CCOP 儿科成分。此外，在 CCOP II 期间，还承诺发展癌症控制研究的基本机制。这是通过招募一名癌症控制协调员来完成，并且非肿瘤科医生参与癌症控制试验。这 Ochsner CCOP 已发展成为全球最大的癌症临床试验项目路易斯安那州，以及该州的主要临床试验力量密西西比州。 Ochsner CCOP 在新资助期内的目标有四个： 1. 增加我们已经很高的癌症治疗方案的收益。这将通过现在增加三名肿瘤科工作人员来完成组成部分：新奥尔良奥克斯纳诊所、巴吞鲁日奥克斯纳诊所、和密西西比州比洛克西，并通过添加一个新组件，新奥尔良东部卫理公会癌症中心。 2. 进一步扩大我们的癌症控制工作的重点是增加我们的参与密西西比成分。 3. 加强少数群体对CCOP的参与纳入新的 CCOP 组成部分卫理公会癌症 (Methodist Cancer) 活动新奥尔良东部中心。卫理公会癌症中心的病人组合大于50%的少数群体患者。 4. 巩固CCOP 强调参与三大研究基地。主要研究基地是NCCTG，其中包括非冲突的 ECOG 协议。其他主要研究基地有 NSABP 和 POG。这 Ochsner CCOP 也将附属于 M.D. Anderson，主要用于癌症控制，但选择不冲突的癌症治疗方案将被利用。 Ochsner CCOP 拥有高效、纪律严明的良好记录。团队并计划继续为 NCI 做出重大贡献临床研究工作。 Ochsner CCOP 将继续强调质量、数量（高应计）和经济（每箱应计成本低）。